We conducted a genome-wide association study for primary open-angle glaucoma (POAG) in 1,263 affected individuals (cases) and 34,877 controls from Iceland. We identified a common sequence variant at 7q31 (rs4236601[A], odds ratio (OR) = 1.36, P = 5.0 × 10 −10 ). We then replicated the association in sample sets of 2,175 POAG cases and 2,064 controls from Sweden, the UK and Australia (combined OR = 1.18, P = 0.0015) and in 299 POAG cases and 580 unaffected controls from Hong Kong and Shantou, China (combined OR = 5.42, P = 0.0021). The risk variant identified here is located close to CAV1 and CAV2, both of which are expressed in the trabecular meshwork and retinal ganglion cells that are involved in the pathogenesis of POAG.
l e t t e r s POAG is a genetically heterogeneous disease that shows linkage to at least 20 genetic loci 3 . Three genes predisposing to glaucoma have been isolated from these loci: MYOC (encoding myocilin) 4 , OPTN (encod ing optineurin) 5 and WDR36 (encoding WD repeat domain 36) 6 , although the association with WDR36 does not replicate in all popula tions. The variants in these genes are rare and may together contribute to 5-6% of all POAG cases 2 . More recently, rare mutations in NTF4 have been found in individuals with POAG 7 , and a genomewide association study (GWAS) yielded two common exonic variants in LOXL1 that explain over 99% of the cases with exfoliation glaucoma (XFG) in individuals of European ancestry 8 . This association with XFG has been replicated in several other populations of European, African and Asian ancestry, although the variants do not associate with POAG in these populations 8, 9 . A recent GWAS conducted in a Japanese population identified three loci with suggestive evidence for association with POAG 10 , although this association was not replicated in an independent study in an Indian population 11 .
To search for genomic variants that confer risk of POAG, we conducted a GWAS on 1,263 POAG cases diagnosed by Icelandic ophthalmologists using established glaucoma criteria 12 and 34,877 population controls from Iceland (Supplementary Note). After qual ity filtering, 303,117 SNPs typed with the Illumina HumanHap300 or HumanHapCNV370 BeadChips were tested for association with POAG. The results were adjusted for relatedness using the method of genomic controls 13 by dividing the χ 2 statistic by the genomic infla tion factor 1.182.
Two highly correlated SNPs, rs4236601[A] and rs1052990[G] (r 2 = 0.64 based on the Utah (CEU) HapMap(r22) samples), reached genomewide significance of P < 1.6 × 10 −7 ( Supplementary Fig. 1 and Supplementary Table 1) . These variants, with OR = 1.36 (P = 5.0 × 10 −10 ) and OR = 1.32 (P = 1.1 × 10 −9 ), respectively, are located within the same linkage disequilibrium (LD) block between CAV1 and CAV2 (encoding caveolin 1 and 2) on 7q31 ( Table 1 and Fig. 1 Table 2 ). None of the variants described in a previous study 10 or any other highly correlated variants associ ated with POAG in the Icelandic samples (Supplementary Table 3) .
We typed rs4236601 in 200 POAG cases and 194 controls from Sweden, in 871 POAG cases and 865 controls from Leicester and Southampton, UK, and in 1,104 POAG cases and 1,001 controls from Australia. In the Swedish set, rs4236601[A] conferred similar risk of POAG as that observed in the Icelandic dataset (OR = 1.33, P = 0.092), whereas the estimated risk was less in the two UK sets (OR = 1.14, P = 0.2 and OR = 1.04, P = 0.75) ( Table 1 ). The Australian sample consisted of three studies-a study from Tasmania (GIST), a study from South Australia (ANZRAG) and the Blue Mountains Eye Study (BMES)-that individually have estimated OR = 1.17 (P = 0.29), OR = 1.25 (P = 0.038) and OR = 1.26 (P = 0.13), respectively. Combined, the replication sets gave OR = 1.18 (95% CI 1.06-1.31, P = 0.0015), and including the discovery set gave OR = 1.27 (95% CI 1.18-1.36, P = 2.2 × 10 −11 ). There was heterogeneity in the effect estimates among the study populations (P het = 0.048); in particular, the estimated effect in the samples from Southampton was low (Table 1) . POAG is a heterogeneous disease and therefore this heterogeneity in the estimated effect sizes is not surprising. In the Southampton samples, the risk was confined to a subset of normal pressure glaucoma cases, whereas we observed no risk for the majority of the cases diagnosed with highpressure glaucoma (Supplementary Table 4 ). Higher risk in normalpressure cases was also observed, although not consistently, in the POAG cases from Iceland and Australia. rs4236601 [A] did not associate with XFG in samples from Iceland and Sweden ( Table 1) .
The estimated population frequency of rs4236601[A] ranges from 20.7% to 28.1% in the four populations studied, and the correspond ing population attributed risk percentage was 12%, calculated using the mean of the population frequencies and the estimated OR of 1.27. About 6% of the individuals in the four populations carry two copies of the risk allele, and their risk of developing POAG is 1.6 times greater than those carrying no risk variant.
The frequency of the risk variant rs4236601[A] differs between ethnicities. In the HapMap populations, the estimated frequency ranges from 45% in the Yoruba population and 28% in the Utah CEPH population to 2% in the Han Chinese population. We did not detect the variant in the 60 HapMap individuals from Japan. We tested the variant for association with POAG in 299 cases and 580 unaffected controls of Chinese origin from Hong Kong and Shantou ( Table 1) . Although the variant is rare, with a frequency of about 1.8% in cases and less than 0.4% in controls, the association was significant and yielded an OR of 5.42 (P = 0.0021). We also tested the variant in 1,027 population controls from Hong Kong, where its frequency is slightly higher than in the unaffected control population and has a frequency Fig. 2 ). Of the 32 CHB surrogate SNPs, we tested 31 for association in the Icelandic sample set but observed no association independent of rs4236601 (Supplementary Table 2 ). Thus, either the risk attributable to this locus differs in European and Chinese populations or there remains an undetected rare causative variant that is not well tagged by existing SNPs in the Utah CEU HapMap samples.
To search for proteincoding mutations responsible for the asso ciation, we sequenced the promoter region, exons and exonintron boundaries of CAV1 and CAV2 in 280 POAG cases and 358 controls from Iceland (Supplementary Note). SNPs identified through this effort were imputed into the remaining Icelandic POAG case and control samples using recently developed methods of longrange phasing of haplotypes in sets of related individuals 14 . Two of the identified SNPs, the nonsynonymous coding variant rs8940 and rs1052990 located in the 3′ untranslated region end of CAV2, were also genotyped in the samples from Australia and Sweden. Although several of the identified variants showed significant association with POAG, none of the tested SNPs remained significant after adjust ing for the effect of rs4236601[A] and none of them account for the association of rs4236601[A] with POAG (Supplementary Table 5 and Supplementary Note). This indicates that rs4236601 is unlikely to tag mutations within the coding region of CAV1 or CAV2.
To evaluate whether the 7q31 variant predisposes to POAG through known risk factors, we tested for association of rs4236601[A] with IOP, CCT, hypertension, type 2 diabetes (T2D) and myopia in 1,713 samples from the Twins Eye Study in Tasmania (TEST) 15 Table 6 ).
The LD block containing rs4236601 contains two known genes, CAV1 and CAV2, and few uncharacterized expressed sequence tags. CAV1 and CAV2 are members of the caveolin gene family that also includes the musclespecific CAV3 gene. CAV1 and CAV2 are expressed in most human cell types, including tissues such as the scleral spur cells 16 , trabecular meshwork 17 and retinal ganglion cells 18 of the eye, but alterations in these tissues are thought to play a role in the pathology of POAG, leading to loss of retinal ganglion cell axons, along with supportive glia and vasculature. Notably, under experimental conditions, CAV1 showed consistent upregulation in the trabecular meshwork after one hour of increased IOP 19 .
CAV1 and CAV2 are involved in the formation of caveolae which are specialized invaginations of the plasma membrane that are rich in cholesterol and other lipids, and they take part in transcytosis. However, it is the role of caveolae in signal transduction through interaction with signaling molecules that has been most extensively studied. Caveolae recruit and compartmentalize various signaling molecules through direct physical interaction mediated by the cave olin scaffolding domain (CSD) in CAV1. This interaction generally results in inhibition of signaling [20] [21] [22] [23] . Caveolins have been suggested as regulators of adult neural stem cell proliferation, as evidenced by increased proliferation of adult neural stem cells in Cav1, Cav2 and Cav3 knockout mice 24 . The regulation by CAV1 of the endothelial nitric oxide synthase (eNOS), an enzyme that produces nitric oxide, is well documented, but the interaction of CAV1 and eNOS leads to eNOS inactivation 25, 26 and reduced nitric oxide production. Nitric oxide plays an important role in the regulation of many physiological functions in the cardiovascular system and the central and peripheral nervous systems. Nitric oxide produced in excessive amounts causes cytotoxicity, neurodegeneration, apoptotic cell death and circulatory failure. In addition to nitric oxide signaling, CAV1 has been shown to be an important regulator of TGFβ signaling through interaction with the TGFβ type 1 receptor. Both nitric oxide and TGFβ signaling have been implicated as culprits in the pathogenesis of POAG 27, 28 .
We tested the effect of rs4236601 on CAV1 and CAV2 mRNA expres sion measured in 747 blood samples and 606 adipose tissue samples 29 .
No correlation between the POAG variant and CAV1 or CAV2 expres sion was observed (data not shown); however, as gene regulation can be highly tissue specific, the effect of rs4236601 on CAV1 and CAV2 expression in ocular tissue, which is more relevant for glaucoma than blood and adipose tissue and where the expression of CAV1 or CAV2 is more likely to influence or lead to disease, can not be excluded.
It is of interest to note that there was a recent report of an associa tion of a SNP, rs3807989[A], within the same LD block as rs4236601 l e t t e r s with the PR interval (an electrocardiogram measurement) and atrial fibrillation 30 . rs3807989 is weakly correlated with rs4236601 (r 2 < 0.01) and does not associate with POAG, nor does rs4236601[A] associate with PR interval or atrial fibrillation. The CAV1CAV2 locus thus adds to the growing list of loci where closely spaced signals show distinct associations with diverse traits. We have identified a sequence variant, rs4236601 [A] , that is associ ated with POAG susceptibility in populations of European and east Asian ancestry. The variant does not have a major effect on known risk factors for POAG such as IOP and central corneal thickness, and it has not been associated with susceptibility to diseases such as T2D, hypertension or myopia that are all risk factors of POAG. This sequence variant is in the same LD block as CAV1 and CAV2. The fre quency of the POAG variant differs between ethnicities; in particular, the frequency of the variant is much lower in east Asian populations than in individuals of European descent. These data highlight the importance of considering the genetic component in the risk of com mon complex diseases in the context of geographic ancestry.
MeTHOdS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
ONLINe MeTHOdS
Subjects and genotyping. Detailed information on all casecontrol sample sets and the genotyping methods are found in the Supplementary Note. Association analysis. For casecontrol association analysis, we used a standard likelihood ratio statistic implemented in the NEMO software 32 to calculate twosided P values and ORs for each individual allele, assuming a multiplica tive model for risk 33 . Allele frequencies were estimated by maximum likeli hood statistics and tests of differences between cases and controls were done using a generalized likelihood ratio test. This method is particularly useful in situations where there are some missing genotypes for the marker of interest, and genotypes of another marker in strong LD with the marker of interest are used to provide some partial information. This was used in the association tests presented in Supplementary Tables 2 and 5 to ensure that the comparison of the highly correlated markers was done using the same number of individuals. To handle uncertainties with phase and missing genotypes, maximum likeli hood estimates, likelihood ratios and P values were computed directly for the observed data, and hence the loss of information due to uncertainty in phase and missing genotypes was automatically captured by the likelihood ratios. Results from multiple casecontrol groups were combined using a Mantel Haenszel model 34 in which the groups were allowed to have different popula tion frequencies for alleles, haplotypes and genotypes but were assumed to have common relative risks. Heterogeneity in the effect estimate was tested assuming that the estimated ORs for different groups follow a lognormal distribution and using a likelihood ratio χ 2 test with degrees of freedom equal to the number of groups compared minus one. The correlation between varia tions in IOP, CCT and spherical equivalent refraction error (SEq), calculated as the average over both eyes, and the number of copies of rs4236601[A] an individual carries was tested using multiple regression, including the age at exam and sex of the individual as explanatory variables. The spherical equiva lent refraction error was calculated as:
SEq spherical error cylinder error = + /2
and myopia was defined when SEq was −3 diopters or more.
Correction for relatedness. Some of the individuals in both the Icelandic control and control groups are related to each other, causing the χ 2 statistic to have a mean >1 and median >0.455. We estimated the inflation factor for the genomewide association by calculating the average of the 303,117 χ 2 statistics, which was a method of genomic control 13 to adjust for both relatedness and potential population stratification. The inflation factor was estimated as 1.182, and the results presented from the genomewide association and in Table 1  and Supplementary Tables 1, 2 Sequencing of CAV1 and CAV2. The exons of CAV1 and CAV2 and the sequences flanking the exons were sequenced in 280 Icelandic POAG cases and 358 Icelandic controls. Further details on the sequencing are provided in the Supplementary Note. The SNPs identified through the sequencing were subsequently imputed into the remaining Icelandic POAG cases and controls using methods of longrange phasing of related individuals 14 and were then tested for association with POAG.
